Scott Rocklage is a managing partner at 5AM Ventures and has more than thirty years of experience in the healthcare management field. His strategic leadership led to the FDA approval of the drugs Cubicin, Teslascan, and Omniscan, and he has invented or been a part of the invention of over 30 different items that have U.S. patents.
As a researcher and writer, Dr. Rocklage has put together over 100 peer-reviewed publications, and he received a Nobel Prize in Chemistry while working in the laboratory of Richard R. Schrook. Before this, he earned a Bachelor’s in Chemistry while attending the University of California, Berkley, and received a PhD from the Massachusetts Institute of Technology in Chemistry.
Scott Rocklage says that the idea for 5AM Ventures came from the fact that the company is in business to help startups, and since 5AM is very early in the morning, it seemed like a good match. Generally, a normal day for Scott can include learning more about recent trends in the life sciences as well as helping companies manage their portfolios.
He brings ideas to life by working with physicians, scientists, and other business people and helping them to better formulate what it is they are thinking about. As an entrepreneur, he feels that some of his greatest strengths include his time management skills and his knack for knowing what is the most important work to get done in a day.
Scott Rocklage feels that he has made many of the right moves in his life and with his work, but if he could start over he would focus more on the people that he chooses to be a part of his team.
Scott also feels like he might take more measured risks, and he advises others that they should go into business for themselves, because they aren’t going to get rich by working for others.
One of Dr. Rocklage’s biggest pieces of advice to new entrepreneurs and business owners is to not get too far away from doing what they do best. While it may be tempting to expand what they offer, it is best to continue to be the best at what it is they excel in.
Read more: Scott Rocklage | Crunchbase